000 | 01242 a2200337 4500 | ||
---|---|---|---|
005 | 20250514195558.0 | ||
264 | 0 | _c20041222 | |
008 | 200412s 0 0 eng d | ||
022 | _a0344-5704 | ||
024 | 7 |
_a10.1007/s00280-004-0887-x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPeek, Richard M | |
245 | 0 | 0 |
_aPrevention of colorectal cancer through the use of COX-2 selective inhibitors. _h[electronic resource] |
260 |
_bCancer chemotherapy and pharmacology _cSep 2004 |
||
300 |
_aS50-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xpharmacology |
650 | 0 | 4 |
_aColorectal Neoplasms _xenzymology |
650 | 0 | 4 | _aCyclooxygenase 2 |
650 | 0 | 4 |
_aEnzyme Inhibitors _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIntestinal Polyps _xdrug therapy |
650 | 0 | 4 |
_aIsoenzymes _xantagonists & inhibitors |
650 | 0 | 4 | _aMembrane Proteins |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aProstaglandin-Endoperoxide Synthases _xmetabolism |
650 | 0 | 4 | _aRisk |
773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 54 Suppl 1 _gp. S50-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00280-004-0887-x _zAvailable from publisher's website |
999 |
_c15008717 _d15008717 |